Purolite, a leading provider of premium ion exchange resin technology, continues its global expansion to meet a growing market and increasing customer demand. To better serve customers in China and the Asia Pacific region, Purolite has also announced plans to build a new resin plant for water and industrial markets in the Quzhou Industrial Park. Construction will begin in 2024, with deliveries to customers expected to commence in late 2026.

Ecolab Inc., the world’s water, hygiene, and infection prevention company, today announced a further expansion of its Purolite business with the addition of a new biologics resin manufacturing facility in Landenberg, Pennsylvania.

The award recognizes Purolite's commitment to the King of Prussia area and the completion of the company's new manufacturing facility.

Purolite, an Ecolab company, celebrated the opening of its new pharmaceutical manufacturing facility in King of Prussia, Pa. The new plant, will produce ion exchange resins for vital healthcare development and pharmaceutical APIs to meet the growing demand for existing and future applications and therapies.

Purolite UK has kicked off the year by announcing Maggie’s Cancer Care Centre in Cardiff as its inaugural UK Charity of the Year for 2022.

Purolite Ltd., a leading manufacturer of resin-based separation, purification and extraction technologies, today announces that its Praesto agarose-based Protein A and Ion Exchange chromatography resins will be made available in South Korea and Singapore.

Purolite's Praesto range of agarose-based chromatography resins move into the commercial manufacturing of FDA-approved biotherapeutics.